Results 191 to 200 of about 50,334 (225)
Some of the next articles are maybe not open access.

Immunotherapies for thyroid eye disease

Current Opinion in Endocrinology, Diabetes & Obesity, 2019
Purpose of review Thyroid eye disease is a complex autoimmune disorder which causes substantial morbidity. It can result in orbital disfigurement, double vision, and visual loss. Consequently, it has a substantial negative effect on quality of life, mental health, and socioeconomic status. Most signs and symptoms of thyroid eye
openaire   +2 more sources

Thyroid-associated eye disease

Strabismus, 2000
Graves' ophthalmopathy (GO) is thought to result from a complex interplay of genetic and environmental factors. Various genes, including those coding for HLA, may determine a patient's susceptibility to the disease and its severity, but in addition, numerous and often unknown environmental factors may determine its course. Once established, the chronic
A E, Heufelder, W, Joba
openaire   +2 more sources

Noninflammatory Thyroid Eye Disease

Ophthalmic Plastic & Reconstructive Surgery, 2019
Purpose: Patients presenting with thyroid eye disease (TED) usually follow a well-defined self-remitting course characterized by an active inflammatory phase followed by an inactive fibrotic phase. We present 3 cases where patients presented primarily with signs of progressive fibrosis and no signs of prior active inflammation.
Shoaib, Ugradar, Daniel B, Rootman
openaire   +2 more sources

Thyroid Eye Disease

Journal of Neuro-Ophthalmology, 2014
The management of active thyroid eye disease (TED) can be a challenging therapeutic dilemma. The pathogenic complexity, disease heterogeneity, clinical unpredictability, and ocular morbidity associated with TED necessitate a team approach.A literature search ending on December 31, 2013, was performed using PubMed (http://www.ncbi.nlm.nih.gov/pubmed ...
M Tariq, Bhatti, Jonathan J, Dutton
openaire   +2 more sources

Thyroid eye disease

Current Opinion in Ophthalmology, 2018
The pathophysiology of thyroid eye disease (TED) is still not fully understood. However, recently described risk factors and molecular findings have brought new insights into the mechanisms of TED and could lead to the emerging use of more targeted therapies.
Zhen, Li   +2 more
openaire   +2 more sources

Eye Changes With Thyroid Disease

Postgraduate Medicine, 1969
Hypothyroidism occasionally produces periorbital myxedema, while hyperthyroidism can lead to exophthalmos. In the latter condition, the patient's upper lids retract, his lids lag when he gazes down, and he blinks infrequently. In its severe form—endocrine exophthalmos—the eyes may bulge forward so much that corneal exposure occurs, leading to possible ...
openaire   +2 more sources

Bibliometrics in thyroid eye disease

Journal of Endocrinological Investigation
Thyroid Eye Disease (TED) is the most common thyroid-related autoimmune inflammatory disorder. Despite a surge in TED-related publications over the past five years-matching the total output of the preceding sixteen years-a systematic bibliometric analysis remains absent.
YuanPing Hai   +9 more
openaire   +2 more sources

Pathogenesis of Thyroid Eye Disease

International Ophthalmology Clinics, 2023
Jane Z. Spadaro, Anita A. Kohli
openaire   +2 more sources

Diabetes- and thyroid-related eye disease

Current Opinion in Ophthalmology, 1993
There is significant morbidity associated with diabetes- and thyroid-related eye diseases. Many different ocular changes are associated with these endocrine disorders. Vitreous hemorrhage from diabetic neovascularization remains the leading cause of blindness, and several recent studies of the etiology of this disorder are of great importance. However,
openaire   +4 more sources

Surgery in Thyroid Eye Disease

International Ophthalmology Clinics, 2023
Javiera, Araya   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy